FDA Inspection 1242835 — Nantong Jinghua Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nantong Jinghua Pharmaceutical Co., Ltd. on May 24, 2024 in Nantong. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nantong (China)